We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NG icon
2776
NovaGold Resources
NG
$3.4B
$138K ﹤0.01%
20,124
+500
+3% +$3.7K
WVVI icon
2777
Willamette Valley Vineyards
WVVI
$11.7M
$138K ﹤0.01%
10,850
AKBA icon
2778
Akebia Therapeutics
AKBA
$250M
$137K ﹤0.01%
47,558
+1,535
+3% +$4.38K
OESX icon
2779
Orion Energy Systems
OESX
$79.7M
$137K ﹤0.01%
3,510
EGY icon
2780
Vaalco Energy
EGY
$587M
$135K ﹤0.01%
46,000
+10,100
+28% +$26.7K
SDC
2781
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$133K ﹤0.01%
25,000
SINT icon
2782
SiNtx Technologies
SINT
$11.1M
$132K ﹤0.01%
5
DDMX
2783
DELISTED
DD3 Acquisition Corp. II Class A Common Stock
DDMX
$132K ﹤0.01%
13,305
ATNX
2784
DELISTED
Athenex, Inc. Common Stock
ATNX
$130K ﹤0.01%
2,164
+39
+2% +$2.84K
KDMN
2785
DELISTED
Kadmon Holdings, Inc.
KDMN
$130K ﹤0.01%
14,916
+743
+5% +$4.23K
AQMS icon
2786
Aqua Metals
AQMS
$9.95M
$128K ﹤0.01%
309
OVID icon
2787
Ovid Therapeutics
OVID
$500M
$128K ﹤0.01%
37,961
ADMS
2788
DELISTED
Adamas Pharmaceuticals
ADMS
$128K ﹤0.01%
26,000
-7,700
-23% -$37.4K
TFFP
2789
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$127K ﹤0.01%
660
GNPX icon
2790
Genprex
GNPX
$2.58M
$125K ﹤0.01%
1
ELTX icon
2791
Elicio Therapeutics
ELTX
$81.9M
$124K ﹤0.01%
+1,270
New +$137K
NGVC icon
2792
Vitamin Cottage Natural Grocers
NGVC
$646M
$124K ﹤0.01%
11,009
REI icon
2793
Ring Energy
REI
$347M
$124K ﹤0.01%
41,900
-33,100
-44% -$84.4K
STIM icon
2794
Neuronetics
STIM
$230M
$124K ﹤0.01%
18,913
+6,200
+49% +$59.5K
VUZI icon
2795
Vuzix
VUZI
$222M
$124K ﹤0.01%
+11,885
New +$159K
INFI
2796
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$124K ﹤0.01%
36,244
-10,700
-23% -$33K
TMBR
2797
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$123K ﹤0.01%
2,694
+1,314
+95% +$64.4K
ETON icon
2798
Eton Pharmaceutcials
ETON
$1.16B
$122K ﹤0.01%
24,206
-193,576
-89% -$1.01M
PZN
2799
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$121K ﹤0.01%
12,339
-279
-2% -$2.99K
LYTS icon
2800
LSI Industries
LYTS
$895M
$120K ﹤0.01%
15,525

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.